🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Integrating neurotrophic and anti-inflammatory pathways: press-needle acupuncture as a multi-target therapy for adolescent depression.

PMID: 41811179 · DOI: 10.1080/00207454.2026.2643312 · The International journal of neuroscience, 2026 · Haomin Zhang, Yufeng Rong, Ruirui Ning, Zhao Yan, Yongqin Zhao, Ying Chen
📄 Abstract

Press needle therapy, may alleviate depressive-like behaviors. Male rats were randomly allocated into four groups ( Press-needle ameliorated depressive-like behaviors in CUMS-exposed rats, restored body weight gain and improved behavioral performance. The treatment upregulated the hippocampal BDNF/TrkB/CREB signaling pathway, increasing BDNF, TrkB, CREB, AKT, and PI3K in the hippocampus. The therapy modulated serotonergic neurotransmission by increasing hippocampal 5-HTT expression, while downregulating 5-HT1A and 5-HT2C receptors and PKA. Notably, press-needle exerted anti-neuroinflammatory effects, reducing hippocampal and serum levels of TNF-α and IL-6. Histopathological analysis confirmed its neuroprotective efficacy, demonstrating attenuated neuronal damage in hippocampal tissues.

Confidence: 0.19 · 5 полей извлечено
Идентификация (6 полей)
Target
—
0.00
Alt. target
—
0.00
Protein family
—
0.00
Functional class
—
0.00
Subcellular loc.
—
0.00
Isoforms (metab/obesity)
—
0.00
Механизм действия (21 полей)
Экспрессия (8 полей)
Tissue expression
hippocampal BDNF, TrkB, CREB, AKT, PI3K, 5-HTT, 5-HT1A, 5-HT2C receptors, PKA, TNF-α, IL-6
0.95
In vitro
—
0.00
In vivo
Press-needle acupuncture ameliorated depressive-like behaviors in CUMS-exposed male rats, restored body weight gain, improved behavioral performance, upregulated hippocampal BDNF/TrkB/CREB signaling, modulated serotonergic neurotransmission, exerted anti-neuroinflammatory effects, and attenuated neuronal damage in hippocampal tissues.
0.95
In silico
—
0.00
Genetic association
—
0.00
Ex vivo
Histopathological analysis confirmed neuroprotective efficacy, demonstrating attenuated neuronal damage in hippocampal tissues.
0.90
Animal model
Male rats, CUMS (chronic unpredictable mild stress) model
0.95
Diet/model
CUMS (chronic unpredictable mild stress) exposure
0.95
Клиника (11 полей)
Drug
—
0.00
Indication
—
0.00
Patient subgroups
—
0.00
Safety concerns
—
0.00
Off-target
—
0.00
Trial stage
—
0.00
Pharma competitors
—
0.00
AE severity
—
0.00
MOA weight loss
—
0.00
Endpoints
—
0.00
Approved
—
0.00